Using Data-Driven, In-Person Discussions to Support Outreach Clients - Insights
In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, speaks with outreach solutions strategists Ellen Dijkman Dulkes and Brianne Newton. They...
Elitza Theel, Ph.D., Director of the Infectious Diseases Serology Laboratory, discusses eastern equine encephalitis virus, which is spread via mosquito bite.
Infectious disease test gains U.S. FDA approval - Insights
An ideal testing partner will offer extensive expertise in assay development and analytical validation services, along with access to biospecimens. In this collaboration example, learn how Mayo Clinic Laboratories’ BioPharma Diagnostics...
Join us at the 12th Annual Alzheimer's & Parkinson's Drug Development Summit - Insights
BioPharma Diagnostics executives will attend the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit, set to take place in Boston, Massachusetts, from April 23 –25. They will be available to meet with attendees to discuss how our...
Week in Review: March 24 - Insights
Today's highlights include: End of Covid emergency will usher in changes across the US health system, vaccine makers prep bird flu shot for humans ‘just in case’; rich nations lock in supplies, and a nuclear power plant leaked contaminated...
Mayo Clinic Laboratory and Pathology Research Roundup: December 19 - Insights
This week's research roundup feature: R0 resection and radiation therapy have been associated with improved overall survival (OS) in patients with thymic carcinoma (TC). Here, we analyzed which subgroups of patients derive the greatest...
The laboratory's role in spurring innovation: Dr. Bill Morice - Insights
William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins “Answers From the Lab” for his weekly leadership update with host Bobbi Pritt, M.D., interim chair of the Department of Laboratory Medicine and Pathology...
Respiratory illness updates and health care economics - Insights
William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D., interim chair of the Department of Laboratory Medicine and Pathology...
Curtis Hanson, M.D., Discusses Prognostic Markers for Chronic Lymphocytic Leukemia - Insights
Curtis Hanson, M.D., discusses the importance of detecting immunoglobulin heavy-chain variable region gene (IGHV) when acquiring prognostic and potentially therapeutic information in chronic lymphocytic leukemia (CLL) patients in CAP TODAY.
Infliximab Test Now Validated for Inflectra - Insights
Mayo Clinic has completed validation of its existing Infliximab Quantitation with Reflex to Antibodies to Infliximab, Serum test for the new biosimilar